SYMBOL:

    Up to 100 tickers separated by a space .....Watch Pre-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ENTREMED INC
(NQSC:ENMD Last Sale: 1.82 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (ENMD : $1.82)
$21 million Market Cap at September 12, 2013
Employs 35.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
9640 Medical Center Drive Research Report Earnings Snapshot - Last 05/15/17
Rockville, MD 20850 Fact Sheet
Phone: 240-864-2600 Financial Statements
Peer Comparison
Annual Reports

James S. Burns, Pres./CEO, Dane R. Saglio, CFO
Develops biopharmaceutical products that inhibit the abnormal growth of new blood vessels associated with cancer, rheumatoid arthritis, and other diseases. IPO at $15 June 11, 1996. Raised $48 MM, selling 3.2 MM shares, 26% of the outstanding. Lead Manager: Allen & Co. Secondary sold units at $2.3125, covering 13 million shares and warrants to purchase up to 6.5 million shares at $2.50 per share.
Historical Charts    Technical Analysis
No Historical Data available for ENMD

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ENMD $1.82 $ 0 $1.8 $1.87 31,816 $1.23 $3.73 11,517
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $20,961

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
29-JUL-10 ENMD Split 1 for 11

A1687
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex